Seer to Present at the Cowen 41st Annual Healthcare Conference

Rhea-AI Summary

Seer, a life sciences company listed on Nasdaq under the symbol SEER, will participate in the Cowen 41^st Annual Healthcare Conference on March 3, 2021. The management will engage in a fireside chat at 8:40 a.m. PT / 11:40 a.m. ET. A live webcast will be accessible on the company’s investor website, with an archived replay available post-conference. Seer focuses on enhancing scientific outcomes through its Proteograph™ Product Suite, designed for comprehensive proteomics analysis in a short time frame.

REDWOOD CITY, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be participating in the upcoming Cowen 41^st Annual Healthcare Conference.

Seer’s management is scheduled to participate in a fireside chat on Wednesday, March 3 at 8:40 a.m. Pacific Time / 11:40 a.m. Eastern Time. A live webcast of the virtual session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference.

About Seer
Seer™ is a life sciences company focused on enabling exceptional scientific outcomes by commercializing transformative products that will drive breakthrough ideas by unlocking the deep, unbiased biological information that can make them a reality. Seer is developing its Proteograph™ Product Suite, which is an integrated solution consisting of consumables, automation instrumentation and proprietary software that performs deep, unbiased proteomics analysis at scale in a matter of hours. Seer designed the Proteograph to be efficient and easy-to-use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution broadly available to life sciences researchers. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Investor Contact
Carrie Mendivil
investor@seer.bio

Media Contact
Karen Possemato
pr@seer.bio

FAQ

When will Seer participate in the Cowen 41st Annual Healthcare Conference?

Seer will participate in the Cowen 41st Annual Healthcare Conference on March 3, 2021.

What time is Seer's fireside chat at the Cowen conference?

Seer's fireside chat is scheduled for 8:40 a.m. Pacific Time / 11:40 a.m. Eastern Time.

Where can I watch the live webcast of Seer's conference participation?

The live webcast can be viewed on Seer's investor website at investor.seer.bio.

What does Seer's Proteograph Product Suite offer?

Seer's Proteograph Product Suite provides deep, unbiased proteomics analysis at scale, designed for efficiency and ease of use.

Is Seer's Proteograph Product Suite intended for diagnostic use?

No, Seer's Proteograph Product Suite is for research use only and is not intended for diagnostic procedures.